Get started
Author

Subhash Ramakrishnan

ORCID: 0009-0006-5801-8985
Observed ORCID: 0009-0006-5801-8985
OpenAlex ID: A5027189255
Clinical practice guideline‐inconsistent chemotherapy‐induced vomiting prophylaxis in pediatric cancer patients in community settings: A Children's Oncology Group study
2024 · Aaron J. Sugalski, Allison C. Grimes, et al. · Pediatric Blood & Cancer · 7
PDF
Characteristics of Health Care Settings Where Adolescents and Young Adults Receive Care for ALL
2024 · Julie A. Wolfson, Allison C. Grimes, et al. · JCO Oncology Practice · 7
PDF
Fertility Preservation Services for Adolescents and Young Adults: 2022 National Cancer Institute Community Oncology Research Program Landscape Assessment
2025 · Erin M. Mobley, Julie Anna Wolfson, et al. · JCO Oncology Practice · 5
PDF
Baseline Characteristics of Parents Enrolled in Children's Oncology Group Study ACCL20N1CD: Financial Toxicity During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States
2025 · Sheila Judge Santacroce, Melissa P. Beauchemin, et al. · Pediatric Blood & Cancer · 5
PDF
Clinical Practice Guideline-Inconsistent Management of Fertility Preservation in Pediatric Cancer Patients in Community Settings: A Children’s Oncology Group Study
2024 · Allison C. Grimes, Aaron J. Sugalski, et al. · Journal of Adolescent and Young Adult Oncology · 3
PDF
Guideline-concordant treatment among adolescents and young adults with acute lymphoblastic leukemia
2025 · Julie A Wolfson, Allison C Grimes, et al. · JNCI Cancer Spectrum · 2
PDF
Baseline characteristics of parents enrolled in ACCL20N1CD: Financial distress during treatment for pediatric acute lymphoblastic leukemia (ALL) in the US.
2024 · Sheila Judge Santacroce, Melissa P. Beauchemin, et al. · JCO Oncology Practice · 1
Baseline practice-level financial screening processes and resources among Children’s Oncology Group National Cancer Institute Community Oncology Research Programs (NCORP).
2024 · Melissa P. Beauchemin, Sheila Judge Santacroce, et al. · JCO Oncology Practice · 1
PDF
Figure S4 from NAPRT Expression and Epigenetic Regulation in Pediatric Rhabdomyosarcoma as a Potential Biomarker for NAMPT Inhibition
2026 · Angela Kim, Prateek Bhardwaj, et al.
Figure S7 from NAPRT Expression and Epigenetic Regulation in Pediatric Rhabdomyosarcoma as a Potential Biomarker for NAMPT Inhibition
2026 · Angela Kim, Prateek Bhardwaj, et al.
Figure S6 from NAPRT Expression and Epigenetic Regulation in Pediatric Rhabdomyosarcoma as a Potential Biomarker for NAMPT Inhibition
2026 · Angela Kim, Prateek Bhardwaj, et al.
Supplementary Tables from NAPRT Expression and Epigenetic Regulation in Pediatric Rhabdomyosarcoma as a Potential Biomarker for NAMPT Inhibition
2026 · Angela Kim, Prateek Bhardwaj, et al.
Figure S1 from NAPRT Expression and Epigenetic Regulation in Pediatric Rhabdomyosarcoma as a Potential Biomarker for NAMPT Inhibition
2026 · Angela Kim, Prateek Bhardwaj, et al.
Figure S5 from NAPRT Expression and Epigenetic Regulation in Pediatric Rhabdomyosarcoma as a Potential Biomarker for NAMPT Inhibition
2026 · Angela Kim, Prateek Bhardwaj, et al.
Data from NAPRT Expression and Epigenetic Regulation in Pediatric Rhabdomyosarcoma as a Potential Biomarker for NAMPT Inhibition
2026 · Angela Kim, Prateek Bhardwaj, et al.
Figure S3 from NAPRT Expression and Epigenetic Regulation in Pediatric Rhabdomyosarcoma as a Potential Biomarker for NAMPT Inhibition
2026 · Angela Kim, Prateek Bhardwaj, et al.
Figure S2 from NAPRT Expression and Epigenetic Regulation in Pediatric Rhabdomyosarcoma as a Potential Biomarker for NAMPT Inhibition
2026 · Angela Kim, Prateek Bhardwaj, et al.
Blinatumomab Care Delivery for Pediatric B-Cell Acute Lymphoblastic Leukemia
2026 · Daniel J. Zheng, Katelyn Oranges, et al. · JAMA Network Open
PDF
Leveraging Large Language Models to Extract Prognostic Pathology Features in Ewing Sarcoma
2026 · Jingwei Huang, Ayesha Batool, et al. · SSRN Electronic Journal
Parental perspectives on financial distress during treatment for childhood acute lymphoblastic leukemia: A qualitative report from Children's oncology group (COG) study ACCL20N1CD
2025 · Joanna Robles, Sheila Santacroce, et al. · Blood
PDF
National landscape of real-world pediatric blinatumomab care delivery in the United States: A report from the Children's Oncology Group
2025 · Daniel Zheng, Katelyn Oranges, et al. · Blood
Works count: 21
Citation count: 31
H-index: 4
I10-index:
Year
Topic
Type